Arbutus Biopharma Corporation
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $204.5M
Liabilities Breakdown FY2021
Total Liabilities: $35.0M
Asset Breakdown
Total Assets: $204.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $109.3M | 53.4% |
| Accounts Receivable | $899.0K | 0.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.0M | 2.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $88.3M | 43.2% |
Liabilities Breakdown
Total Liabilities: $35.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.2M | 9.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $31.9M | 90.9% |